These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2159595)

  • 21. Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents.
    Marone G; Lichtenstein LM; Plaut M
    J Pharmacol Exp Ther; 1980 Nov; 215(2):469-78. PubMed ID: 6255128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
    Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rate-limiting steps in the beta-adrenergic stimulation of cardiac calcium current.
    Frace AM; Méry PF; Fischmeister R; Hartzell HC
    J Gen Physiol; 1993 Mar; 101(3):337-53. PubMed ID: 8386216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resensitization of hepatocyte glucagon-stimulated adenylate cyclase can be inhibited when cyclic AMP phosphodiesterase inhibitors are used to elevate intracellular cyclic AMP concentrations to supraphysiological values.
    Murphy GJ; Houslay MD
    Biochem J; 1988 Jan; 249(2):543-7. PubMed ID: 2449179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists.
    Jurevicius J; Fischmeister R
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):295-9. PubMed ID: 8552625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylcholine inhibits Ca2+ current by acting exclusively at a site proximal to adenylyl cyclase in frog cardiac myocytes.
    Jurevicius J; Fischmeister R
    J Physiol; 1996 Mar; 491 ( Pt 3)(Pt 3):669-75. PubMed ID: 8815202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon activates Ca2+ and Cl- channels in rat hepatocytes.
    Aromataris EC; Roberts ML; Barritt GJ; Rychkov GY
    J Physiol; 2006 Jun; 573(Pt 3):611-25. PubMed ID: 16581855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.
    Boutjdir M; Méry PF; Hanf R; Shrier A; Fischmeister R
    Mol Pharmacol; 1990 Dec; 38(6):758-65. PubMed ID: 1701212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide synthase does not participate in negative inotropic effect of acetylcholine in frog heart.
    Méry PF; Hove-Madsen L; Chesnais JM; Hartzell HC; Fischmeister R
    Am J Physiol; 1996 Apr; 270(4 Pt 2):H1178-88. PubMed ID: 8967355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of intact hepatocytes with the calcium ionophore A23187 perturbs both the synthesis and the degradation of the second messenger cyclic AMP. Actions on adenylate cyclase and cyclic AMP phosphodiesterase activities.
    Irvine FJ; Houslay MD
    Biochem Pharmacol; 1988 Jul; 37(14):2773-9. PubMed ID: 2456067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The phorbol ester TPA inhibits cyclic AMP phosphodiesterase activity in intact hepatocytes.
    Irvine F; Pyne NJ; Houslay MD
    FEBS Lett; 1986 Nov; 208(2):455-9. PubMed ID: 2430836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased glucagon-stimulated cyclic AMP production by isolated liver cells of rats with type 2 diabetes.
    Portha B; Chamras H; Broer Y; Picon L; Rosselin G
    Mol Cell Endocrinol; 1983 Sep; 32(1):13-26. PubMed ID: 6313452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic AMP phosphodiesterases and Ca2+ current regulation in cardiac cells.
    Fischmeister R; Hartzell HC
    Life Sci; 1991; 48(25):2365-76. PubMed ID: 1646365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in some metabolic effects of isoprenaline and glucagon in normotensive and spontaneously hypertensive rats.
    Staneva-Stoycheva D; Bogoslovova T
    Acta Physiol Pharmacol Bulg; 1976; 2(4):40-5. PubMed ID: 196481
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum contains a potent factor that decreases beta-adrenergic receptor-stimulated L-type Ca2+ current in cardiac myocytes.
    Banach K; Bünemann M; Hüser J; Pott L
    Pflugers Arch; 1993 May; 423(3-4):245-50. PubMed ID: 8391681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative relations between cyclic AMP and contraction as affected by stimulators of adenylate cyclase and inhibitors of phosphodiesterase.
    Kukovetz WR; Pöch G; Wurm A
    Adv Cyclic Nucleotide Res; 1975; 5():395-414. PubMed ID: 165677
    [No Abstract]   [Full Text] [Related]  

  • 37. Evidence that cyclic AMP is not involved in the chronotropic action of glucagon in the adult mouse heart.
    Clark CM
    Endocrinology; 1976 Jul; 99(1):23-9. PubMed ID: 181238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actions of vasopressin and isoprenaline on the ionic transport across the isolated frog skin in the presence and the absence of adenyl cyclase inhibitors MDL12330A and SQ22536.
    Lippe C; Ardizzone C
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 99(1-2):209-11. PubMed ID: 1711430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
    Larsson PG; Haffner F; Brłnstad GO; Christoffersen T
    Br J Cancer; 1979 Nov; 40(5):768-73. PubMed ID: 228692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inositol hexakisphosphate increases L-type Ca2+ channel activity by stimulation of adenylyl cyclase.
    Yang SN; Yu J; Mayr GW; Hofmann F; Larsson O; Berggren PO
    FASEB J; 2001 Aug; 15(10):1753-63. PubMed ID: 11481223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.